Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice

Neurochemical Research

Volumn 38, Issue 1, 2013, Pages 201-207

  Liu, Kangyong ^a,b   Shi, Nan ^a   Sun, Yinyi ^b   Zhang, Ting ^b   Sun, Xiaojiang ^b  

^a Shanghai Pudong New Area Zhoupu Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Autophagy; MPTP; Parkinson's disease; Rapamycin

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA SYNUCLEIN; DOPAMINE; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; MONOAMINE; NEUROTRANSMITTER; RAPAMYCIN; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MARKER; DOPAMINERGIC NERVE CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LIGHT CHAIN; MALE; MOUSE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; WESTERN BLOTTING;

ALPHA-SYNUCLEIN; ANIMALS; ANTI-BACTERIAL AGENTS; AUTOPHAGY; BIOGENIC MONOAMINES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROTUBULE-ASSOCIATED PROTEINS; MPTP POISONING; NEOSTRIATUM; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE, SECONDARY; SIROLIMUS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MUS;

EID: 84871606902     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0909-8     Document Type: Article

References (33)

1. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5(6):525-535
2. Giasson BI, Duda JE, Murray IV et al (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290(5493):985-989
3. Spillantini MG, Schmidt ML, Lee VM et al (1997) Alpha-synuclein in lewy bodies. Nature 388(6645):839-840
4. Polymeropoulos MH (1998) Autosomal dominant Parkinson's disease and alpha-synuclein. Ann Neurol 44(3 Suppl 1):S63-S64
5. Liu KY, Liu CF, Qian JJ (2008) Autophagic pathway and probable mechanism in degradation of mutant α-synuclein in PC12 cells. Chin J Neurol 41(1):51-56
6. Anglade P, Vyas S, Javoy-Agid F et al (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12(1):25-31
7. Kruger R, Kuhn W, Muller T et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18(2):106-108
8. Yang YPLK, Qian JJ et al (2007) The abnormal aggregation of alpha-synuclein induces autophagic programmed cell death in PC12 cells. Eur J Neurol 14(Suppl):341-343
9. Kamada Y, Funakoshi T, Shintani T et al (2000) Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 150(6):1507-1513
10. Yu L, Alva A, Su H et al (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304(5676):1500-1502
11. Ohsawa Y, Isahara K, Kanamori S et al (1998) An ultrastructural and immunohistochemical study of PC12 cells during apoptosis induced by serum deprivation with special reference to autophagy and lysosomal cathepsins. Arch Histol Cytol 61(5):395-403
12. Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6(4):463-477
13. Shimizu S, Kanaseki T, Mizushima N et al (2004) Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6(12):1221-1228
14. Kanzawa T, Zhang L, Xiao L et al (2005) Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24(6):980-991
15. Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443(7113):780-786
16. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67-93
17. Chan L, Gaston R, Hariharan S (2001) Evolution of immunosuppression and continued importance of acute rejection in renal transplantation. Am J Kidney Dis 38(6 Suppl 6):S2-S9
18. Moore DJ, West AB, Dawson VL et al (2005) Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28:57-87
19. Fujiwara H, Hasegawa M, Dohmae N et al (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160-164
20. Rieker C, Engblom D, Kreiner G et al (2011) Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling. J Neurosci 31(2):453-460
21. Hsu LJ, Sagara Y, Arroyo A et al (2000) Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157(2):401-410
22. Petrucelli L, Dawson TM (2004) Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann Med 36(4):315-320
23. Song DD, Shults CW, Sisk A et al (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186(2):158-172
24. Webb JL, Ravikumar B, Atkins J et al (2003) Alpha-synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278(27):25009-25013
25. Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290(5497):1717-1721
26. Mizushima N, Sugita H, Yoshimori T et al (1998) A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J Biol Chem 273(51):33889-33892
27. Abeliovich H, Dunn WA Jr, Kim J et al (2000) Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol 151(5):1025-1034
28. Sarkar S, Davies JE, Huang Z et al (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 282(8):5641-5652
29. Wellington CL, Singaraja R, Ellerby L et al (2000) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem 275(26):19831-19838
30. Malagelada C, Jin ZH, Greene LA (2008) RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J Neurosci 28(53):14363-14371
31. Malagelada C, Jin ZH, Jackson-Lewis V et al (2010) Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci 30(3):1166-1175
32. Ravikumar B, Berger Z, Vacher C et al (2006) Rapamycin pre-treatment protects against apoptosis. Hum Mol Genet 15(7):1209-1216
33. Klionsky DJ, Ohsumi Y (1999) Vacuolar import of proteins and organelles from the cytoplasm. Annu Rev Cell Dev Biol 15:1-32